Furthermore, TGFβ and IFNβ administration improve memory impairments, neuronal apoptosis and synaptic plasticity in mouse and rat AD models (Chen et al., 2015; Chavoshinezhad et al., 2019; Hu et al., 2019). The gene discussed is TGFB1; the disease is Alzheimer disease.